Table 3.

Number of Patients with Type and Grade of Toxicity for Paclitaxel Once Every 2 Weeks Versus Once Per Week

Adverse Event	Grade for Paclitaxel Every 2 Weeks (n = 1,162)								Grade for Paclitaxel Once Per Week (n = 1,139)
	≤ 2		3		4		5		≤ 2		3		4		5
	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%
Hemoglobin	1,135	97.7	25	2.2	2	0.2	0	0.0	1,123	98.6	16	1.4	0	0.0	0	0.0
Leukocytes	1,153	99.2	7	0.6	2	0.2	0	0.0	1,057	92.8	72	6.3	10	0.9	0	0.0
Neutrophils	1,140	98.1	17	1.5	5	0.4	0	0.0	1,000	87.8	105	9.2	34	3.0	0	0.0
Neurologic	961	82.7	193	16.6	8	0.7	0	0.0	1,020	89.6	115	10.1	4	0.4	0	0.0
Dermatologic/skin	1,132	97.4	30	2.6	0	0.0	0	0.0	1,117	98.1	22	1.9	0	0.0	0	0.0
Allergy	1,146	98.6	16	1.4	0	0.0	0	0.0	1,133	99.5	6	0.5	0	0.0	0	0.0
Febrile neutropenia	1,160	99.8	2	0.2	0	0.0	0	0.0	1,138	99.9	0	0.0	1	0.1	0	0.0
Musculoskeletal pain	1,035	89.1	124	10.7	3	0.3	0	0.0	1,106	97.1	33	2.9	0	0.0	0	0.0
Fatal event	1,161	99.9	0	0.0	0	0.0	4	0.3	1,139	100	0	0.0	0	0.0	3	0.3
All adverse events	750	64.5	384	33.0	24	2.1	4	0.3	727	63.8	363	31.9	48	4.2	3	0.3